Zdrowie i gospodarka · 16/07/2019
FDA Clears MIOCHOL for Approval Following Withdrawal Determination
The FDA has determined that MIOCHOL, an acetylcholine chloride intraocular solution, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.
Source: Federal Register — Food and Drug AdministrationOpen original release →